Salivary gland pleomorphic adenoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 31, Issue 1, 2008, Pages 95-99

  Mendenhall, William M ^a   Mendenhall, Charles M ^b   Werning, John W ^c   Malyapa, Robert S ^a   Mendenhall, Nancy P ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b PHOEBE PUTNEY MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Pleomorphic adenoma; Salivary gland; Treatment outcomes

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; DISEASE COURSE; FACIAL NERVE INJURY; HISTOPATHOLOGY; HUMAN; MIDDLE AGED; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAROTID GLAND; PAROTIDECTOMY; PLEOMORPHIC ADENOMA; POSTOPERATIVE COMPLICATION; PRESERVATION; SALIVARY GLAND CANCER; REVIEW; SALIVARY GLAND TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOMA, PLEOMORPHIC; HUMANS; NEOPLASM RECURRENCE, LOCAL; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME;

EID: 42449135794     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181595ae0     Document Type: Article

References (25)

1. O'Brien CJ. Current management of benign parotid tumors-the role of limited superficial parotidectomy. Head Neck. 2003;25:946-952.
2. Piekarski J, Nejc D, Szymczak W, et al. Results of extracapsular dissection of pleomorphic adenoma of parotid gland. J Oral Maxillofac Surg. 2004;62:1198-1202.
3. Lourenco SV, Kapas S, Williams DM, et al. Expression patterns of integrins on pleomorphic adenoma and adenoid cystic carcinoma: study on specimens and in vitro investigation of the effects of extracellular matrix on the expression of these adhesion molecules. J Oral Pathol Med. 2004;33:574-580.
4. Ohtake S, Cheng J, Ida H, et al. Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry. J Oral Pathol Med. 2002;31:590-597.
5. Alves FA, Perez DE, Almeida OP, et al. Pleomorphic adenoma of the submandibular gland: clinicopathological and immunohistochemical features of 60 cases in Brazil. Arch Otolaryngol Head Neck Surg. 2002;128:1400-1403.
6. Donovan DT, Conley JJ. Capsular significance in parotid tumor surgery: reality and myths of lateral lobectomy. Laryngoscope. 1984;94:324-329.
7. Laccourreye H, Laccourreye O, Cauchois R, et al. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope. 1994;104: 1487-1494.
8. Dawson AK, Orr JA. Long-term results of local excision and radiotherapy in pleomorphic adenoma of the parotid. Int J Radiat Oncol Biol Phys. 1985;11:451-455.
9. Hodge CW, Morris CG, Werning JW, et al. Role of radiotherapy for pleomorphic adenoma. Am J Clin Oncol. 2005;28:148-151.
10. Blevins NH, Jackler RK, Kaplan MJ, et al. Facial paralysis due to benign parotid tumors. Arch Otolaryngol Head Neck Surg. 1992;118:427-430.
11. Ethunandan M, Witton R, Hoffman G, et al. Atypical features in pleomorphic adenoma-a clinicopathologic study and implications for management. Int J Oral Maxillofac Surg. 2006;35:608-612.
12. Nouraei SA, Ferguson MS, Clarke PM, et al. Metastasizing pleomorphic salivary adenoma. Arch Otolaryngol Head Neck Surg. 2006;132:788-793.
13. Hamada T, Matsukita S, Goto M, et al. Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence. J Clin Pathol. 2004;57:813-821.
14. Saleh ER, Franca CM, Marques MM. Neural adhesion molecule (N-CAM) in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. J Oral Pathol Med. 2003;32:562-567.
15. do Prado RF, Consolaro A, Taveira LA. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. Med Oral Patol Oral Cir Bucal. 2006;11:E247-E251.
16. Natvig K, Soberg R. Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study. Head Neck. 1994;16:213-217.
17. Maran AG, Mackenzie IJ, Stanley RE. Recurrent pleomorphic adenomas of the parotid gland. Arch Otolaryngol. 1984;110:167-171.
18. Buchman C, Stringer SP, Mendenhall WM, et al. Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence. Laryngoscope. 1994;104:1231-1234.
19. Myssiorek D, Ruah CB, Hybels RL. Recurrent pleomorphic adenomas of the parotid gland. Head Neck. 1990;12:332-336.
20. Ravasz LA, Terhaard CH, Hordijk GJ. Radiotherapy in epithelial tumors of the parotid gland: case presentation and literature review. Int J Radiat Oncol Biol Phys. 1990;19:55-59.
21. Barton J, Slevin NJ, Gleave EN. Radiotherapy for pleomorphic adenoma of the parotid gland. Int J Radiat Oncol Biol Phys. 1992;22:925-928.
22. Liu FF, Rotstein L, Davison AJ, et al. Benign parotid adenomas: a review of the Princess Margaret Hospital experience. Head Neck. 1995; 17:177-183.
23. Chen AM, Garcia J, Bucci MK, et al. Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2006;66:1031-1035.
24. Samson MJ, Metson R, Wang CC, et al. Preservation of the facial nerve in the management of recurrent pleomorphic adenoma. Laryngoscope. 1991;101:1060-1062.
25. Douglas JG, Einck J, Austin-Seymour M, et al. Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands. Head Neck. 2001;23:1037-1042.